Clinical Trial Update: TREg Activation in the Treatment of the PELADE (Alopecia Areata) [Phase 3]

View source ↗

Summary

The document notes the completion of a Phase 3 trial evaluating TREg activation for alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• TREg

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Alopecia Areata | Phase 3 | Status: COMPLETED